ENS 57868

v t e ENS Event
05:00 Aug 12, 2025
Title	Medical Event
Event Description	The following is a summary of information provided by the Nebraska Department of Health and Human Services via phone and email: The licensee reported that on August 12, 2025, a patient was to receive a 200 mCi Lu-177 (Pluvicto) treatment for prostate cancer per a written directive, but was administered a 156 microcurie Ra-223 (Xofigo) treatment for metastatic prostate cancer instead. The licensee's initial estimate is that the patient received a 13 rem whole-body dose and 665 rem to the bone marrow. There were no immediate implications for patient health reported. The referring physician and patient have been notified of the event. A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.

ENS 57868 +/-
Where
The Nebraska Medical Center Omaha, Nebraska (NRC Region 4)
License number:	01-88-01
Organization:	Ne Div Of Radioactive Materials
Reporting

Agreement State
Time - Person (Reporting Time:+34.68 h1.445 days <br />0.206 weeks <br />0.0475 months <br />)
Opened:	Michael Gries 15:41 Aug 13, 2025
NRC Officer:	Robert A. Thompson
Last Updated:	Aug 13, 2025
57868 - NRC Website
v • d • e

v t e Emergency Notification System
The Nebraska Medical Center with Agreement State
WEEKMONTHYEAR2025-08-12T05:00:00 [Table view]
[ENS list for The Nebraska Medical Center]

Navigation menu